Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 62 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Accord Healthcare Inc. | Activity: Sales and Operations | Company Description Accord Healthcare is the marketing subsidiary of Intas Pharmaceuticals, an India-based company that focuses on manufacturing generic pharmaceuticals and biosimilars for the global market. | Location Durham |
| |
Company AegisCN LLC | Activity: Research and Development | Company Description AegisCN develops technologies and treatments targeting neurological diseases and inflammation. | Location Durham |
| |
Company Aestas Pharma Inc. | Activity: Research and Development | Company Description Aestas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the detection, early treatment and reversal of Alzheimer’s disease when clinical signs are not yet pronounced. | Location Durham |
| |
Company Allucent (Cary) | Activity: Contract Research and Testing | Company Description Allucent provides contract research services, including preclinical and clinical study design and management, regulatory assessments, data management and statistics, CMC program management, medical writing and submission of regulatory documents. | Location Cary |
| |
Company Altavera Analytics | Activity: Contract Research and Testing | Company Description Altavera Analytics provides custom solutions for bioinformatics, utilizing cloud-based workflows and statistical analysis of genomic data. Altavera specializes in biomedicine, including immunology and neurology, as well as agricultural applications, including plant molecular biology and CRISPR screens. | Location Durham |
| |
Company Amgen | Activity: Production and Manufacturing | Company Description Amgen will manufacture therapeutics for cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. The site is expected to be operational by 2025. | Location Apex |
| |
Company Arrivo BioVentures LLC | Activity: Research and Development | Company Description Arrivo BioVentures accelerates biologics and small molecules from IND readiness through a clinical proof of concept, with biologics in development for dermatologic conditions. | Location Morrisville |
| |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park |
| |
Company Atrium Health Division of Therapeutic Research and Development | Activity: Research and Development | Company Description The Division of Therapeutic Research and Development at Atrium Health conducts clinical studies, patient-focused translational research and outcomes research. | Location Charlotte |
| |
Company Avicenna Biosciences Inc. | Activity: Research and Development | Company Description Avicenna Biosciences is a drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate optimization process for small molecule drug development. | Location Durham |
| |
Company Biogen | Activity: Production and Manufacturing | Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. The Drug Substance Campus in RTP is home to biologics production and a patient services contact center. | Location Research Triangle Park |
| |
Company Biogen (Oral Solid Dose Facility) | Activity: Production and Manufacturing | Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. This site houses oral solid dose and anti-sense oligonucleotide production, packaging and fill/finish operations, as well as a Global Business Services center. | Location Research Triangle Park |
| |
Company Black Swan Pharmaceuticals Inc. | Activity: Research and Development | Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. | Location Wake Forest |
| |
Company Caidya | Activity: Contract Research and Testing | Company Description Caidya provides full global CRO service to pharmaceutical and biotechnology companies, working across all major therapeutic areas including oncology, gastroenterology and women's health and rare disease. | Location Morrisville |
| |
Company Centaur Bio Inc. | Activity: Research and Development | Company Description Centaur Bio develops technology that facilitates precision drug delivery, which will potentially improve treatments for solid tumors and CNS disorders. | Location Charlotte |
| |
Company CLAIRIgene LLC | Activity: Research and Development | Company Description CLAIRIgene develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. | Location Durham |
| |
Company Cloud Pharmaceuticals Inc. | Activity: Contract Research and Testing | Company Description Cloud Pharmaceuticals designs and develops novel drug molecules using computational design for a wide range of therapeutic areas including cancer, inflammation, CNS disorders and rare diseases. | Location Research Triangle Park |
| |
Company CogniKey Pharma LLC | Activity: Contract Research and Testing | Company Description CogniKey Pharma develops drugs to treat cognitive impairment in CNS disorders. CogniKey has a special interest in the treatment of Mild Cognitive Impairment (MCI). | Location Winston-Salem |
| |
Company Cognosci Inc. | Activity: Research and Development | Company Description Cognosci develops neurorestorative therapies for Alzheimer's disease, multiple sclerosis, traumatic brain injury, nerve crush and other disease and trauma indications. | Location Durham |
| |
Company DelAQUA Pharmaceuticals Inc. | Activity: Research and Development | Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. | Location Chapel Hill |
| |
Company Eisai Inc. | Activity: Sales and Operations | Company Description Eisai discovers, develops and markets pharmaceuticals in neurology and oncology-critical care. This site supports global partnerships, quality assurance and supply chain for the company. | Location Raleigh |
| |
Company Encoded Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Encoded is developing and commercializing gene therapies for pediatric central nervous system (CNS) disorders with its cell-selective targeting and regulation platform. | Location Morrisville |
| |
Company ENVIGEN Pharmaceuticals Inc. | Activity: Research and Development | Company Description ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders. | Location Durham |
| |
Company Generys Biopharmaceuticals Corp. | Activity: Research and Development | Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. | Location Chapel Hill |
| |
Company Grifols (RTP) | Activity: Sales and Operations | Company Description Grifols manufactures and markets plasma-derived medicines and other biopharmaceutical solutions to treat chronic, rare, and, at times, life-threatening conditions in the therapeutic areas of immunology, pulmonology, hematology, thrombolytics and neurology. | Location Research Triangle Park |
| |
Company GSK (Durham) | Activity: Research and Development | Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. | Location Durham |
| |
Company Ironshore Pharmaceuticals Inc. | Activity: Sales and Operations | Company Description Ironshore Pharmaceuticals develops, commercializes and distributes novel pharmaceuticals, including a novel oral treatment for ADHD with delayed-release properties. | Location Morrisville |
| |
Company Karamedica Inc. | Activity: Research and Development | Company Description Karamedica has developed a plasma treatment of batch quantities of chitosan and other biopolymers in order to lower endotoxin levels. Karamedica is also currently developing a nanoparticle therapy for cerebral amyloid angiopathy. | Location Raleigh |
| |
Company Krenitsky Pharmaceuticals Inc. | Activity: Research and Development | Company Description Krenitsky Pharmaceuticals discovers and develops drug candidates, with a focus on disorders of the nervous system. | Location Chapel Hill |
| |
Company Kriya Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Kriya Therapeutics develops AAV-based gene therapies for the treatment of type 1 and type 2 diabetes, severe obesity, and other indications. This location is the company's internal manufacturing facility. | Location Morrisville |
| |
Company LadeRx LLC | Activity: Research and Development | Company Description LadeRx is developing new technology for diagnostic radiology. | Location Durham |
| |
Company LVM Biosciences Inc. | Activity: Research and Development | Company Description LVM Biosciences develops therapeutics for epilepsy, stroke, anxiety, migraine, and pain. | Location Chapel Hill |
| |
Company Merz Therapeutics | Activity: Research and Development | Company Description Merz Therapeutics develops and commercializes neurological therapeutic treatment solutions for patients who suffer from movement disorders and neurological health conditions. | Location Raleigh |
| |
Company Mind Medicine Inc. | Activity: Research and Development | Company Description Mind Medicine is a clinical-stage biopharmaceutical company developing products using the therapeutic potential of psychedelics to treat brain health disorders, with a focus on psychiatry, addiction, pain and neurology. | Location Durham |
| |
Company NeuroGT Inc. | Activity: Research and Development | Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. | Location Chapel Hill |
| |
Company North Carolina Clinical Research | Activity: Contract Research and Testing | Company Description North Carolina Clinical Research conducts phase 1 through 4 trials at its outpatient clinical research facility. Study indications include allergy (seasonal and perennial), asthma, COPD, vaccine, migraine, bioequivalent studies and celiac disease. | Location Raleigh |
| |
Company Olfax LLC | Activity: Research and Development | Company Description Olfax Medical is developing nasally administered therapeutics to help patients avoid the harmful and addictive side effects of systemic pharmaceuticals. | Location Asheville |
| |
Company Osmotica Pharmaceutical Corp. | Activity: Research and Development | Company Description Osmotica Pharmaceutical specializes in drug-delivery technologies and neurology-based therapies, including a treatment for Parkinson's disease. | Location Wilmington |
| |
Company PETNET Solutions Inc. (Winston-Salem) | Activity: Production and Manufacturing | Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. | Location Winston-Salem |
| |
Company PETNET Solutions Inc., A Siemens Healthineers Company (Durham) | Activity: Production and Manufacturing | Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. | Location Durham |
| |
Company Pfizer Inc. (Durham) | Activity: Research and Development | Company Description Pfizer develops gene therapies to treat rare genetic central nervous system (CNS) and neuromuscular diseases. Pfizer's BioTherapeutics Pharmaceutical Sciences site in Durham houses clinical manufacturing space and analytical research development laboratories. | Location Durham |
| |
Company Pinnacle Hill LLC | Activity: Research and Development | Company Description Pinnacle Hill, a joint venture of UNC-Chapel Hill and Deerfield Management, works with faculty to accelerate the development of their research projects to discover and develop new drugs and therapies for unmet needs. | Location Chapel Hill |
| |
Company Praetego Inc. | Activity: Research and Development | Company Description Praetego is preclinical stage pharmaceutical company committed to improving health outcomes by addressing chronic diseases of aging, starting with Alzheimer’s Disease. Praetego’s novel small molecules inhibit a systemic driver of oxidative stress at the initiation of pathology. | Location Research Triangle Park |
| |
Company Regennova Inc. | Activity: Research and Development | Company Description Regennova develops therapeutics for inflammatory diseases and neurological disorders, including cerebral stroke, traumatic brain injury, Alzheimer's and sepsis. | Location Durham |
| |
Company Resilio Therapeutics LLC | Activity: Research and Development | Company Description Resilio Therapeutics is developing treatments for neurodegenerative diseases such as Alzheimer's Disease. | Location Durham |
| |
Company Revivo Therapeutics Inc. | Activity: Research and Development | Company Description Revivo Therapeutics is a clinical stage company developing therapies for cognitive dysfunction and neuroprotection. | Location Durham |
| |
Company Roivant Sciences Inc. | Activity: Research and Development | Company Description Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease. | Location Durham |
| |
Company RTI International | Activity: Contract Research and Testing | Company Description RTI, an independent, nonprofit institute, offers scientific and technical expertise in social and laboratory sciences, engineering and international development to government and commercial clients worldwide. | Location Research Triangle Park |
| |
Company Sentiens LLC | Activity: Research and Development | Company Description Sentiens develops nutraceutical products targeting addictive behavior. | Location Charlotte |
| |
Company SiNON Nano Sciences Inc. | Activity: Research and Development | Company Description SiNON is developing technology to treat neurological diseases by increasing the ability of drugs to cross the blood brain barrier (BBB). | Location Durham |